Endoscopic response as early as 12 weeks with upadacitinib is associated with improvements in clinical outcomes and QOL in CD.

Paternal HBV infection prior to pregnancy may be associated with increased CHD risk in offspring, according to results of a large matched cohort study.

Recommendations have been developed to address evaluation and management of chronic constipation, according to updated American Society of Colon and Rectal Surg ...

Time-restricted eating (TRE) may improve diabetes outcomes, independent of energy intake, according to a study.

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Women are underrepresented in the Child Neurology Society’s (CNS) leadership and awards despite comprising most of the child neurology field.

The employment of telemedicine in the neurologic space may be valid for initial consultation, depending on the clinical scenario.

The FDA has updated the prescribing information for Veozah (fezolinetant) to include a warning regarding the risk of serious liver injury.

Statistics from 2023 on US obesity rates reveal that in every US state, 1 in every 5 people now has obesity, according to data released.

The FDA has approved Tremfya® (guselkumab) for the treatment of adult patients with moderately to severely active ulcerative colitis (UC).

Predictors of inadequate bowel preparation (IBP) in colonoscopy include use of Medicaid insurance, low education levels, current tobacco smoking, and Black race, among other factors, according to a ...

Neuroendocrine and gastrointestinal stromal tumors are the fastest increasing upper GI cancers among young women. Incidence rates of upper gastrointestinal (UGI) cancer have increased faster in young ...